Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
0.990
+0.006 (0.62%)
At close: Nov 20, 2024, 4:00 PM
1.040
+0.050 (5.05%)
After-hours: Nov 20, 2024, 6:49 PM EST

Citius Oncology Statistics

Total Valuation

CTOR has a market cap or net worth of $70.59 million.

Market Cap 70.59M
Enterprise Value n/a

Important Dates

The next estimated earnings date is Friday, November 29, 2024, before market open.

Earnings Date Nov 29, 2024
Ex-Dividend Date n/a

Share Statistics

CTOR has 71.30 million shares outstanding.

Current Share Class 71.30M
Shares Outstanding 71.30M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) n/a
Owned by Institutions (%) 0.07%
Float 5.25M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.92
P/TBV Ratio 4.14
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.32

Current Ratio 0.32
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -85.28% and return on invested capital (ROIC) is -51.73%.

Return on Equity (ROE) -85.28%
Return on Assets (ROA) -24.23%
Return on Capital (ROIC) -51.73%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, CTOR has paid $576,000 in taxes.

Income Tax 576,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -90.93% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -90.93%
50-Day Moving Average 1.26
200-Day Moving Average 8.59
Relative Strength Index (RSI) 36.47
Average Volume (20 Days) 83,988

Short Selling Information

The latest short interest is 39,417, so 0.06% of the outstanding shares have been sold short.

Short Interest 39,417
Short Previous Month 10,597
Short % of Shares Out 0.06%
Short % of Float 0.75%
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -18.95M
Pretax Income n/a
Net Income -19.52M
EBITDA n/a
EBIT -18.95M
Earnings Per Share (EPS) -$0.29
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) 17.03M
Book Value Per Share 0.25
Working Capital -21.39M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CTOR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -27.66%
FCF Yield n/a

Analyst Forecast

The average price target for CTOR is $6.00, which is 506.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target $6.00
Price Target Difference 506.06%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a